MedPath

Benazepril

Generic Name
Benazepril
Brand Names
Amlobenz, Lotensin, Lotensin Hct, Lotrel
Drug Type
Small Molecule
Chemical Formula
C24H28N2O5
CAS Number
86541-75-5
Unique Ingredient Identifier
UDM7Q7QWP8

Overview

Benazepril, brand name Lotensin, is a medication used to treat high blood pressure (hypertension), congestive heart failure, and chronic renal failure. Upon cleavage of its ester group by the liver, benazepril is converted into its active form benazeprilat, a non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor.

Background

Benazepril, brand name Lotensin, is a medication used to treat high blood pressure (hypertension), congestive heart failure, and chronic renal failure. Upon cleavage of its ester group by the liver, benazepril is converted into its active form benazeprilat, a non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor.

Indication

Benazepril is indicated for the treatment of hypertension. It may be used alone or in combination with thiazide diuretics.

Associated Conditions

  • Diabetic Nephropathy
  • Heart Failure
  • Hypertension
  • Non-diabetic Nephropathy

FDA Approved Products

Benazepril Hydrochloride
Manufacturer:Amneal Pharmaceuticals of New York LLC
Route:ORAL
Strength:5 mg in 1 1
Approved: 2021/09/01
NDC:53746-751
Amlodipine and Benazepril Hydrochloride
Manufacturer:REMEDYREPACK INC.
Route:ORAL
Strength:10 mg in 1 1
Approved: 2023/05/12
NDC:70518-1928
Benazepril Hydrochloride
Manufacturer:Amneal Pharmaceuticals LLC
Route:ORAL
Strength:5 mg in 1 1
Approved: 2019/02/18
NDC:65162-751
Benazepril Hydrochloride
Manufacturer:Amneal Pharmaceuticals LLC
Route:ORAL
Strength:40 mg in 1 1
Approved: 2019/02/18
NDC:65162-754
Amlodipine and Benazepril Hydrochloride
Manufacturer:Aurobindo Pharma Limited
Route:ORAL
Strength:40 mg in 1 1
Approved: 2021/11/10
NDC:65862-585

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath